Company news
New CRISPR/Cas9 license agreement to advance disease model development
May 31 2024
Ricoh Company, Ltd has announced a non-exclusive licensing agreement with ERS Genomics Ltd for access to foundational CRISPR/Cas9 genome editing technology patents in the USA and Japan.
CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise modification of targeted genome sequences. It plays a crucial role in drug discovery and is utilised in various research fields.
In 2022, Ricoh acquired Elixirgen Scientific, Inc, which specialises in rapid and efficient differentiation of human iPS cells and mRNA design, production, and management. Combining these technologies with CRISPR/Cas9, Ricoh aims to enhance the prediction of drug mechanisms for patients with diverse genetic backgrounds and to improve mRNA design speed and efficiency. This integration allows for the creation of reliable disease models, including those for rare diseases, potentially shortening drug development timelines and increasing success rates.
Ricoh is expanding the application of Elixirgen Scientific's technology by utilising its expertise in digital and artificial intelligence technologies. This initiative aims to accelerate personalised medicine, drug discovery research, and regenerative medicine. Ricoh is committed to advancing drug development research through the diverse solutions offered by Elixirgen Scientific.
Summit Pharmaceuticals International Corporation, a subsidiary of Sumitomo Corporation, is the exclusive representative of ERS Genomics in Japan.
More information online
Digital Edition
Lab Asia 32.1 Feb 2025
February 2025
Chromatography Articles - Comparing volumetric and thermal flowmeters for assessing and validating liquid chromatography performance Mass Spectrometry & Spectroscopy Articles - The importa...
View all digital editions
Events
SPS Smart Production Solutions Guangzhou
Feb 25 2025 Guanghzou, China
Feb 25 2025 Amsterdam, Netherlands
Feb 27 2025 Kathmandu, Nepal
Mar 01 2025 Boston, MA, USA
Mar 02 2025 Bethesda, MD, USA